Latest Regulation News

Page 4 of 141
Percheron Therapeutics announces Dr Michael Baker as incoming CEO, replacing Dr James Garner who steps down after three years. Baker’s appointment aligns executive incentives with shareholder value as the company prepares for a pivotal HMBD-002 clinical trial.
Ada Torres
Ada Torres
10 Aug 2026
Contact Energy (ASX:CEN) posted a 62% jump in FY26 net profit to NZD 423 million, driven by its Manawa acquisition and a near 98% renewable generation mix, while committing to net zero emissions by 2035.
Maxwell Dee
Maxwell Dee
10 Aug 2026
American Tungsten & Antimony plans to restart and expand the Del Sol Refinery and White Spar Mine in the US, contingent on completing their acquisition. The company is preparing for increased processing capacity and new product lines while engaging with regulators and engineering firms.
Maxwell Dee
Maxwell Dee
6 Aug 2026
AdAlta’s lead CAR-T therapy EW-001 has achieved a rare clinical milestone with one mesothelioma patient remaining cancer-free two years after treatment, and a second reaching one-year survival, underscoring the therapy’s potential durability in a notoriously difficult cancer.
Ada Torres
Ada Torres
5 Aug 2026
Light & Wonder's Q2 2026 sees net income jump 26% to $120 million, driven by strong Gaming and iGaming growth. The company sticks to its 2026 outlook, targeting mid- to high-single-digit EBITDA growth and aims to reduce leverage below 3.0x by mid-2027.
Victor Sage
Victor Sage
5 Aug 2026
Future Metals NL has launched an updated Scoping Study for its Panton PGM-Ni-Cr Project, weighing a greenfield standalone operation against leveraging the idle Savannah processing facility to identify a cost-effective development route.
Maxwell Dee
Maxwell Dee
4 Aug 2026
Stakk Ltd's combined pro forma FY2026 revenue with ParaScript has climbed to approximately A$45 million, surpassing earlier forecasts by 9%. Both companies outperformed initial revenue assumptions, setting a stronger baseline ahead of integration benefits.
Sophie Babbage
Sophie Babbage
4 Aug 2026
Control Bionics has achieved FDA registration for its NeuroStrip surface EMG platform, cementing its medical device status in the US and bolstering its appeal in clinical and research markets.
Ada Torres
Ada Torres
4 Aug 2026
FleetPartners has received a non-binding, conditional indicative offer from SG Fleet to acquire all outstanding shares at A$3.601 each, subject to due diligence and regulatory approvals.
Claire Turing
Claire Turing
3 Aug 2026
Pure Resources has appointed Vice Admiral Michael Noonan AO, retired Chief of the Royal Australian Navy, to its Advisory Board for a year-long term, bolstering its defence strategy and engagement with Australian and allied government agencies.
Maxwell Dee
Maxwell Dee
3 Aug 2026
Peppermint Innovation Ltd (ASX:PIL) reported a 171% jump in group revenue for the June quarter, powered by a 577% surge in its Bizmoto revenue and a successful pilot of its QRPh Person-to-Merchant payment platform that tripled monthly transaction values. The company is advancing its ASX reinstatement while expanding its digital payments ecosystem in the Philippines.
Claire Turing
Claire Turing
31 July 2026
Echelon Resources has finalised its divestment of Cue Energy shares, boosting cash and cutting debt, while progressing key drilling and gas supply agreements.
Maxwell Dee
Maxwell Dee
31 July 2026

Browse the archive

Full archive